Lerer Hippeau — 2024 Investments
5 investments dated 2024 · listed companies and verified rows first · show all
Ayoh makes flavored mayonnaise condiments, branded as "Sando Sauce," that blend creamy mayo with ingredients like pickles, spices, herbs, and vinegars for use on sandwiches, burgers, fries, and vegetables.
ConsumerDirect to ConsumerFoodTechGolden, US
Molly BazDavid McCormick(Founder)inDavid K. McCormick(Executive Officer, Director)
BoardGreer Tessler(Director)Logan Langberg(Director)inMolly Willet(Director)
Co-investorsHabitat PartnersImaginary Venture CapitalSiddhi Capital
Caladan Bio develops high-throughput benchtop bioreactor hardware and software for laboratory bioprocessing, enabling faster experimentation and lower costs for biotech R&D teams.
AI & Machine LearningBiotechHardwareNew York, US
Michael Kobida(Founder)inRob Jauquet(Founder)inMichael J. Kobida(Executive Officer, Director)Robert Jauquet(Executive Officer, Director)
Co-investorsCollaborative FundRitual CapitalTwelve BelowWireframe VenturesFactorial Capital
Footprint is a unified identity and privacy platform that gives companies tools to verify, authenticate, and secure identity, including one-click KYC backed by a cryptographic data vault.
AI & Machine LearningCybersecurityFintechSaaS
Alex Grinman(Co-founder, CTO)inEli Wachs(Co-founder, CEO)in
Co-investorsIndex VenturesKhosla VenturesPalm Tree Crew InvestmentsQED InvestorsAnimal CapitalBoxGroup+2 more
Runhappy (Tildei) automates event and booking inquiry management for experience venues and entertainment operators, capturing inquiries across web, SMS, email, and voice 24/7 and working them through to confirmed bookings.
AI & Machine LearningSaaSSales TechNew York City, US
Kevin Dutra(Founder)inMark Ghermezian(Executive Officer, Director, Promoter)Manisha Shah(Founder)
Co-investorsGradient Venturesm]x[v CapitalMaccabee VenturesVine VenturesLudlow VenturesMXV Capital+1 more
Cellular Intelligence is a cell therapy company developing engineered cell treatments for diseases, including a Phase 2-ready therapy for Parkinson's disease acquired from Novo Nordisk.
AI & Machine LearningBiotechDeep TechBoston, US
Micha Breakstone, Ph.D.(CEO & co-founder)Allon Klein, Ph.D.(Scientific Co-founder)Olivier Pourquié, Ph.D.(Scientific Co-founder)Cliff Tabin, Ph.D.(Scientific Co-founder)Jay Shendure, M.D., Ph.D.(Scientific Co-founder)Micah Breakstone(Executive Officer, Director, Promoter)
Co-investorsKhosla VenturesNext Coast VenturesSamsung NextAMD VenturesFusionMontage Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.